These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26996664)

  • 1. A platform for interrogating cancer-associated p53 alleles.
    D'Brot A; Kurtz P; Regan E; Jakubowski B; Abrams JM
    Oncogene; 2017 Jan; 36(2):286-291. PubMed ID: 26996664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of a p53 homologue in Drosophila melanogaster.
    Jin S; Martinek S; Joo WS; Wortman JR; Mirkovic N; Sali A; Yandell MD; Pavletich NP; Young MW; Levine AJ
    Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7301-6. PubMed ID: 10860994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common gain of function of p53 cancer mutants in inducing genetic instability.
    Liu DP; Song H; Xu Y
    Oncogene; 2010 Feb; 29(7):949-56. PubMed ID: 19881536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating Drosophila p53 as a model system for studying cancer mutations.
    Herzog G; Joerger AC; Shmueli MD; Fersht AR; Gazit E; Segal D
    J Biol Chem; 2012 Dec; 287(53):44330-7. PubMed ID: 23135266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guardian ancestry: fly p53 and damage-inducible apoptosis.
    Nordstrom W; Abrams JM
    Cell Death Differ; 2000 Nov; 7(11):1035-8. PubMed ID: 11139275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant p53 gain-of-function in cancer.
    Oren M; Rotter V
    Cold Spring Harb Perspect Biol; 2010 Feb; 2(2):a001107. PubMed ID: 20182618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide expression analysis identifies a modulator of ionizing radiation-induced p53-independent apoptosis in Drosophila melanogaster.
    van Bergeijk P; Heimiller J; Uyetake L; Su TT
    PLoS One; 2012; 7(5):e36539. PubMed ID: 22666323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation.
    Slingerland JM; Jenkins JR; Benchimol S
    EMBO J; 1993 Mar; 12(3):1029-37. PubMed ID: 8458321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models.
    Kenzelmann Broz D; Attardi LD
    Carcinogenesis; 2010 Aug; 31(8):1311-8. PubMed ID: 20097732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient generation of P53 biallelic knockout Diannan miniature pigs via TALENs and somatic cell nuclear transfer.
    Shen Y; Xu K; Yuan Z; Guo J; Zhao H; Zhang X; Zhao L; Qing Y; Li H; Pan W; Jia B; Zhao HY; Wei HJ
    J Transl Med; 2017 Nov; 15(1):224. PubMed ID: 29100547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into wild-type and mutant p53 functions provided by genetically engineered mice.
    Donehower LA
    Hum Mutat; 2014 Jun; 35(6):715-27. PubMed ID: 24415648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes.
    Monti P; Perfumo C; Bisio A; Ciribilli Y; Menichini P; Russo D; Umbach DM; Resnick MA; Inga A; Fronza G
    Mol Cancer Res; 2011 Mar; 9(3):271-9. PubMed ID: 21343334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gain of function of p53 cancer mutants in disrupting critical DNA damage response pathways.
    Song H; Xu Y
    Cell Cycle; 2007 Jul; 6(13):1570-3. PubMed ID: 17598983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 binding prevents phosphatase-mediated inactivation of diphosphorylated c-Jun N-terminal kinase.
    Gowda PS; Zhou F; Chadwell LV; McEwen DG
    J Biol Chem; 2012 May; 287(21):17554-17567. PubMed ID: 22467874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity.
    Viotti J; Duplan E; Caillava C; Condat J; Goiran T; Giordano C; Marie Y; Idbaih A; Delattre JY; Honnorat J; Checler F; Alves da Costa C
    Oncogene; 2014 Apr; 33(14):1764-75. PubMed ID: 23644658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming activity of mutant human p53 alleles.
    Slingerland JM; Benchimol S
    J Cell Physiol; 1991 Sep; 148(3):391-5. PubMed ID: 1918170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chk2 regulates irradiation-induced, p53-mediated apoptosis in Drosophila.
    Peters M; DeLuca C; Hirao A; Stambolic V; Potter J; Zhou L; Liepa J; Snow B; Arya S; Wong J; Bouchard D; Binari R; Manoukian AS; Mak TW
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11305-10. PubMed ID: 12172011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional functionality of germ line p53 mutants influences cancer phenotype.
    Monti P; Ciribilli Y; Jordan J; Menichini P; Umbach DM; Resnick MA; Luzzatto L; Inga A; Fronza G
    Clin Cancer Res; 2007 Jul; 13(13):3789-95. PubMed ID: 17606709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribozyme-mediated induction of apoptosis in human cancer cells by targeted repair of mutant p53 RNA.
    Shin KS; Sullenger BA; Lee SW
    Mol Ther; 2004 Aug; 10(2):365-72. PubMed ID: 15294183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.
    Bouchalova P; Nenutil R; Muller P; Hrstka R; Appleyard MV; Murray K; Jordan LB; Purdie CA; Quinlan P; Thompson AM; Vojtesek B; Coates PJ
    J Pathol; 2014 Jul; 233(3):238-46. PubMed ID: 24687952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.